De novo versus recurrent metastatic breast cancer affects the extent of brain metastases Bio JooJee Hung KimSung Jun Ahn Research 12 June 2024
Long-term outcomes of central neurocytoma – an institutional experience Yufan YangNitin WadhwaniSean Sachdev Case Study 12 June 2024
Laser interstitial thermal therapy followed by consolidation stereotactic radiosurgery (LITT-cSRS) in patients with newly diagnosed brain metastasis Rajiv DharnipragadaRena A. ShahClark C. Chen Research 12 June 2024
Primary central nervous system lymphomas in immunocompromised patients require specific response criteria Nina SchulzLucia NichelliCaroline Houillier Research 12 June 2024
Correction to: Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in differentiating between brain tumor progression versus pseudoprogression and radionecrosis Richard DagherMona GadLicia P. Luna Correction 10 June 2024
Amino-acid PET as a prognostic tool after post Stupp protocol temozolomide therapy in high-grade glioma patients Adeline ZinszShamimeh AhrariAntoine Verger Research Open access 06 June 2024
Intracranial angioleiomyoma: a case series of seven patients and review of the literature Meltem IvrenAsan CherkezovAlexander Younsi Case Study Open access 06 June 2024
White matter connectivity and social functioning in survivors of pediatric brain tumor Matthew C. HockingRobert T. SchultzJohn D. Herrington Research Open access 05 June 2024
Clinical and molecular features of patients with IDH1 wild-type primary glioblastoma presenting unexpected short-term survival after gross total resection Mariko ToyodaIchiyo ShibaharaToshihiro Kumabe Research 05 June 2024
Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis Tugce KutukYanjia ZhangRupesh Kotecha Research 05 June 2024
Correction to: Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data Arya ShettySu WangAkdes Serin Harmanci Correction 04 June 2024
Central nervous system regulation of diffuse glioma growth and invasion: from single unit physiology to circuit remodeling Thiebaud PicartShawn Hervey-Jumper Review Open access 04 June 2024
Frailty in patients with IDH-mutant gliomas: experience from a high-volume tumor center David P. BrayNolan M. StubbsKimberly B. Hoang Research 04 June 2024
Role of microsurgical tumor burden reduction in patients with breast cancer brain metastases considering molecular subtypes: a two-center volumetric survival analysis Jacopo BellomoAnna Maria ZeitlbergerStefanos Voglis Case Study Open access 03 June 2024
The role of adjuvant radiotherapy for intracranial malignant meningiomas: analysis of a nationwide database Chung-Han HoLi-Tsun ShiehSheng-Yow Ho Case Study 30 May 2024
Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data Arya ShettySu WangAkdes Serin Harmanci Research 29 May 2024
Predictors and surgical outcome of hemorrhagic metastatic brain malignancies Laurèl RauschenbachPia KolbeRamazan Jabbarli Research Open access 27 May 2024
Constitutive type-1 interferons signaling activity in malignant gliomas Chunzhao LiLang LongNan Ji Research 24 May 2024
Predicting post-surgical functional status in high-grade glioma with resting state fMRI and machine learning Patrick H. LuckettMichael O. OlufawoEric C. Leuthardt Research Open access 24 May 2024
Clinical Course after Carmustine Wafer Implantation for Newly Diagnosed Adult-type Diffuse Gliomas; A controlled propensity matched analysis of a single center cohort Takahiro OnoHayato SuzukiHiroaki Shimizu Research 23 May 2024
Rapid DNA methylation-based classification of pediatric brain tumors from ultrasonic aspirate specimens Michèle SimonLuis P. KuschelPhilipp Euskirchen Research Open access 21 May 2024
Enhancing Temozolomide (TMZ) chemosensitivity using CRISPR-dCas9-mediated downregulation of O6-methylguanine DNA methyltransferase (MGMT) Yasamin YousefiReza NejatiMajid Mojarrad Research 19 May 2024
The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients Hanne BlakstadEduardo Erasmo Mendoza MirelesPetter Brandal Research Open access 19 May 2024
Impact of frailty on survival glioblastoma, IDH-wildtype patients Benoît HudelistAngela EliaJohan Pallud Research 19 May 2024
Medical treatment of functional pituitary adenomas, trials and tribulations Cristina CapatinaFelicia Alexandra HanzuMaria Fleseriu Review 18 May 2024 Pages: 197 - 213
Correction to: Results from a first-in-human phase I safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma Omer DoronTamika WongJohn A. Boockvar Correction Open access 17 May 2024 Pages: 237 - 238
Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors Rebecca RonsleyKristine A. KarvonenSarah E. S. Leary Research 16 May 2024 Pages: 215 - 224
Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240) Iulia Peciu-FlorianuQuentin Vannod-MichelNicolas Reyns Research Open access 16 May 2024
Histopathological correlation of brain tumor recurrence vs. radiation effect post-radiosurgery as detected by MRI contrast clearance analysis: a validation study Victor GoulenkoVenkatesh Shankar MadhugiriDheerendra Prasad Case Study 15 May 2024
Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice David R. RaleighWilliam C. ChenMinesh Mehta Correspondence 14 May 2024
Precision oncology in neurofibromatosis type 1: quantification of differential sensitivity to selumetinib in plexiform neurofibromas using single-cell RNA sequencing Archis R. BhandarkarShaan BhandarkarRobert J. Spinner Research 13 May 2024
The incidence of brain metastases in breast cancer according to molecular subtype and stage: a 10-year single institution analysis Christopher PoletesBardia AmaniradDavid B. Shultz Research 13 May 2024
Reply to “Elevating the findings by substituting in ‘ISarcoPRM’” Li Feng TanMervyn Lim Correspondence 07 May 2024
Frailty in intracranial meningioma resection: the risk analysis index demonstrates strong discrimination for predicting non-home discharge and in-hospital mortality Michael M. CovellJoanna M. RoyChristian A. Bowers Research 07 May 2024
Pharmaceutical equivalent 5-aminolevulinic acid fluorescence guided resection of central nervous system tumors: feasibility, safeness and cost-benefit considerations Erasmo Barros da Silva JrRicardo RaminaMaurício Coelho Neto Case Study 06 May 2024
Use of complementary therapies and supportive measures of patients with intracranial gliomas—a prospective evaluation in an outpatient clinic Malte OttenhausenMirjam RenovanzFlorian Ringel Research Open access 06 May 2024
Revisiting prognostic factors of gliomatosis cerebri in adult-type diffuse gliomas Ilah ShinYongsik SimSeung-Koo Lee Research 03 May 2024 Pages: 239 - 247
Treatment, healthcare utilization and outcomes in patients with glioblastoma in Ontario: a 10-year cohort study Wafa BaqriKathryn RzadkiSunit Das Research 03 May 2024
Benchmarking palliative care practices in neurooncology: a german perspective Anna Cecilia Lawson McLeanAaron Lawson McLeanon behalf of the German Consortium for Excellence in Neurooncology, Palliative Care (GCE-NPC) Research Open access 02 May 2024 Pages: 333 - 343
Leveraging radiomics and machine learning to differentiate radiation necrosis from recurrence in patients with brain metastases Mustafa M. BasreeChengnan LiAndrew M. Baschnagel Research 30 April 2024 Pages: 307 - 316
Superficial meningioma with bone involvement: surgical strategies and clinical outcomes Gang LiQilong TianQing Cai Research 30 April 2024 Pages: 27 - 33
Results from a first-in-human phase I safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma Omer DoronTamika WongJohn A. Boockvar Research Open access 26 April 2024 Pages: 225 - 235
Exploring the impact of primary care utilization and health information exchange upon treatment patterns and clinical outcomes of glioblastoma patients Megan ParkerFoad KazemiDebraj Mukherjee Research 25 April 2024 Pages: 345 - 353
PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor Shizun WangDan ZhangYuqin Liu Research 25 April 2024 Pages: 139 - 149
Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator Ryosuke MatsudaRyosuke MaeokaIchiro Nakagawa Research 25 April 2024
Correction to: Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status Johanna JostKlaus Völkerfor the MMH Trial Investigators Correction Open access 24 April 2024 Pages: 47 - 47
Single versus multiple reoperations for recurrent intracranial meningiomas Francesco MaiuriSergio CorvinoMarialaura Del Basso De Caro Case Study Open access 24 April 2024
Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data Takanari OkamotoRyo MizutaKatsuhiro Masago Research 23 April 2024 Pages: 489 - 499
Intraoperative radiotherapy combined with spinal stabilization surgery—a novel treatment strategy for spinal metastases based on a first single-center experiences P. KraussC. L. WolfertE. Shiban Research Open access 23 April 2024
Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy Ting SunBin LiuYanyan Li Research 23 April 2024